Organization: BlueRock Therapeutics

Opinion Leader: Continued government support is critical to maintain Ontario’s global competitiveness in regenerative medicine

Ongoing provincial government support for the Ontario Institute for Regenerative Medicine (OIRM) is critical to maintain Ontario’s global competitiveness in the fast-growing field of regenerative medicine which is developing cutting-edge products and therapies resulting from stem cell research, Dr. Duncan Stewart, president and scientific director of OIRM, and Dr. Tim Smith, chair of the board of directors at OIRM, say in an op-ed.

NEOMED plans Montreal expansion; proves new pharma R&D model works

Montreal’s NEOMED Institute needs more space to accommodate growing demand for its facilities and services. Discussions are underway with an unnamed third party equity investor to finance the expansion of its Laval facility with a decision expected within weeks. NEOMED’s growth proves it is possible to come up with a business model that can retain top talent in a region when big pharma employers decide to move out.

Quebec life sciences strategy targets $4 billion in foreign investment

The long-awaited 2017-2027 Quebec Life Sciences Strategy is positioning the province to be in the top five North American life sciences clusters within a decade. The strategy aims to leverage its scientific expertise, particularly in precision medicine and big data, by attracting $4 billion in private investment to boost industry employment and increase the number of Quebec-based firms and their contribution to provincial GDP.

Canada’s regenerative medicine sector poised to soar with better funding and collaboration: report

Canadian expertise and achievements in regenerative medicine (RM) could be at a turning point if strategic steps are taken to increase stable funding and achieve greater coordination among the many federal and provincial players. Those are the key observations of a report issued by the Council of Canadian Academies (CCA), which was based on a two-day workshop held last October to provide policy makers with pointers for growing the sector and realizing greater economic and health benefits.